This law provides a framework for commercial industrial hemp production in Montana following approval by the federal government. Provisions added to the 2014 Farm Bill (Section 7606) defined industrial hemp under federal law and recognized state agricultural departments' authority to develop research pilot programs to study the growth, cultivation, and/or marketing of industrial hemp.
Cannabinoids are a group of 21-carbon–containing terpenophenolic compounds produced uniquely by Cannabis species (e.g., Cannabis sativa L.).[1,2] These plant-derived compounds may be referred to as phytocannabinoids. Although delta-9-tetrahydrocannabinol (THC) is the primary psychoactive ingredient, other known compounds with biologic activity are cannabinol, cannabidiol (CBD), cannabichromene, cannabigerol, tetrahydrocannabivarin, and delta-8-THC. CBD, in particular, is thought to have significant analgesic, anti-inflammatory, and anxiolytic activity without the psychoactive effect (high) of delta-9-THC.
Cannabis contains a seemingly unique class of chemicals, the cannabinoids, of which more than 60 have been described, but only a few are psychoactive. Cannabinoids are produced in specialized epidermal glands, which differ notably in distribution on different organs of the plant (high concentrations occur on the upper surface of the young leaves and young twigs, on the tepals, stamens, and especially on the perigonal bract). Given this distribution, the glands would seem to be protective of young and reproductive above-ground tissues (the roots lack glands). Two classes of epidermal glands occur—stalked and sessile (Fig. 8), but in either case the glandular cells are covered by a sheath under which resin is accumulated, until the sheath ruptures, releasing resin on the surface. The resin is a sticky mixture of cannabinoids and a variety of terpenes. The characteristic odor of the plant is due to the abundant terpenes, which are not psychoactive. The more important cannabinoids are shown in Fig. 9. In the plant the cannabinoids exist predominantly in the form of carboxylic acids, which decarboxylate with time or when heated. Delta-9-tetrahydrocannabinol (D9-THC, or simply THC) is the predominant psychoactive component. Other THC isomers also occur, particularly D8-THC, which is also psychoactive. Technically, the euphoric psychological effects of THC are best described by the word psychotomimetic. Cannabidiol (CBD) is the chief non-psychotomimetic cannabinoid. A THC concentration in marijuana of approximately 0.9% has been suggested as a practical minimum level to achieve the (illegal) intoxicant effect, but CBD (the predominant cannabinoid of fiber and oilseed varieties) antagonizes (i.e. reduces) the effects of THC (Grotenhermen and Karus 1998). Concentrations of 0.3% to 0.9% are considered to have “only a small drug potential” (Grotenhermen and Karus 1998). Some cannabinoid races have been described, notably containing cannabichromene (particularly in high-THC forms) and cannabigerol monomethyl ether (in some Asian strains). The biosynthetic pathways of the cannabinoids are not yet satisfactorily elucidated, although the scheme shown in Fig. 10 is commonly accepted. At least in some strains, THC is derived from cannabigerol, while in others it may be derived from CBD. CBN and D8-THC are considered to be degradation products or analytical artifacts (Pate 1998a).
Yet, even with this progress, hemp businesses seem to face difficulty expanding in the US as they face challenges in traditional marketing and sales approaches. According to a case study done by Forbes, hemp businesses and startups have had difficulty marketing and selling non-psychoactive hemp products, as some online advertising platforms and financial institutions do not distinguish between hemp and marijuana.[100]

For kids with severe forms of epilepsy, changes in medication levels can be extremely dangerous. “If their levels go low, they’re at increased risk of seizures, which could lead to an emergency room visit or an ICU stay,” Knupp said. “On the other hand, if their levels go high, their side effects can increase dramatically.” Side effects from epilepsy medications can range anywhere from drowsiness to vomiting to heart arrhythmia, Knupp noted. “For some people that could mean a minor inconvenience, but for some patients it could be life-threatening.”
The most pressing need of the hemp industry in North America is for the breeding of more productive oilseed cultivars. At present, mainly European cultivars are available, of which very few are suitable for specialized oilseed production. More importantly, hempseed oil is not competitive, except in the novelty niche market, with the popular food oils. As argued above, to be competitive, hemp should produce approximately 2 t/ha; at present 1 t/ha is considered average to good production. Doubling the productive capacity of a conventional crop would normally be considered impossible, but it needs to be understood just how little hemp has been developed as an oilseed. There may not even be extant land races of the kind of hemp oilseed strains that were once grown in Russia, so that except for a very few very recent oilseed cultivars, there has been virtually no breeding of oilseed hemp. Contrarily, hemp has been selected for fiber to the point that some breeders consider its productivity in this respect has already been maximized. Fiber strains have been selected for low seed production, so that most hemp germplasm has certainly not been selected for oilseed characteristics. By contrast, drug varieties have been selected for very high yield of flowers, and accordingly produce very high yield of seeds. Drug varieties have been observed to produce more than a kilogram of seed per plant, so that a target yield of several tonnes per hectare is conceivable (Watson and Clarke 1997). Of course, the high THC in drug cultivars makes these a difficult source of germplasm. However, wild plants of C. sativa have naturally undergone selection for high seed productivity, and are a particularly important potential source of breeding germplasm.

A population-based case-control study of 611 lung cancer patients revealed that chronic low Cannabis exposure was not associated with an increased risk of lung cancer or other upper aerodigestive tract cancers and found no positive associations with any cancer type (oral, pharyngeal, laryngeal, lung, or esophagus) when adjusting for several confounders, including cigarette smoking.[7]
Cannabinoids may also contribute to pain modulation through an anti-inflammatory mechanism; a CB2 effect with cannabinoids acting on mast cell receptors to attenuate the release of inflammatory agents, such as histamine and serotonin, and on keratinocytes to enhance the release of analgesic opioids has been described.[45-47] One study reported that the efficacy of synthetic CB1- and CB2-receptor agonists were comparable with the efficacy of morphine in a murine model of tumor pain.[48]

This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the use of Cannabis and cannabinoids in the treatment of people with cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.

I am currently doing a research paper on the benefits of hemp, and medicinal marijuana. Lets just say I am “experianced”, and knowledgable when it comes to the advantages. (c’mon, stoners cannot be that ‘spaced out’ if even we see the impact hemp itself could make) I chose this topic to voice not only my opinion on the matter, but the facts in the matter. Thank you for the valuble information on your site! It has helped to improve my paper for sure!!
According to researchers, 25 percent of all cancer patients use medical marijuana. Cancer patients are finding relief from medical cannabis. And they want to know more about it. Research conducted at St. George’s University of London, found the two most common cannabinoids in marijuana, tetrahydrocannabinol (THC) and cannabidiol (CBD), weakened the ferocity of cancer cells and made them more susceptible to radiation treatment. Other studies have shown that medical marijuana treatments can slow the growth of cancer cells and halt their spread to other parts of the body.
“With more than 2,000 wine and liquor stores from Buffalo to Montauk, we offer existing retail space with quick and cheap access to the market in every corner of the state,” reads the website for the group, which is called The Last Store on Main Street. “That means more tax revenue, and sooner, for the State to fulfill basic responsibilities and invest in the future of our neighborhoods.”
Hearst and Rockefeller did not want Hemp or any form of Cannabis interfering with their lucrative paper, pharmaceutical and oil industries. Hemp is versatile and renewable. It can be used for food, medicine, fuel, paper, clothing, plastic, building materials; just about anything paper and oil is used for. These bastard wealthy people have done a disservice to all people and for the sake of lining their already copiously rich pockets. They and those like them are criminals of the worst order
In the United States, cannabis is overall the number four value crop, and is number one or two in many states including California, New York and Florida, averaging $3,000 per pound ($6,600/kg).[244][245] Some believe it generates an estimated $36 billion market.[246] Some have argued that this estimate is methodologically flawed, and makes unrealistic assumptions about the level of marijuana consumption. Other estimates claiming to correct for this flaw claim that the market is between $2.1-$4.3 billion.[237] The United Nations Office on Drugs and Crime claims in its 2008 World Drug Report that typical U.S. retail prices are $10–15 per gram (approximately $280–420 per ounce). Street prices in North America are known to range from about $40–$400 per ounce ($1.4–$14/g), depending on quality.[247]
Not until the end of the 20th century was the specific mechanism of action of THC at the neuronal level studied.[citation needed] Researchers have subsequently confirmed that THC exerts its most prominent effects via its actions on two types of cannabinoid receptors, the CB1 receptor and the CB2 receptor, both of which are G protein-coupled receptors.[133] The CB1 receptor is found primarily in the brain as well as in some peripheral tissues, and the CB2 receptor is found primarily in peripheral tissues, but is also expressed in neuroglial cells.[134] THC appears to alter mood and cognition through its agonist actions on the CB1 receptors, which inhibit a secondary messenger system (adenylate cyclase) in a dose-dependent manner. These actions can be blocked by the selective CB1 receptor antagonist rimonabant (SR141716), which has been shown in clinical trials to be an effective treatment for smoking cessation, weight loss, and as a means of controlling or reducing metabolic syndrome risk factors.[135] However, due to the dysphoric effect of CB1 receptor antagonists, this drug is often discontinued due to these side effects.[136]
Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; however, there is no single agreed-upon definition.[38][39] The rigorous scientific study of cannabis as a medicine has been hampered by production restrictions and other federal regulations.[40] There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms.[41][42][43] Its use for other medical applications is insufficient for conclusions about safety or efficacy.
In 1951, Congress passed the Boggs Act, which for the first time included Cannabis with narcotic drugs. In 1970, with the passage of the Controlled Substances Act, marijuana was classified by Congress as a Schedule I drug. Drugs in Schedule I are distinguished as having no currently accepted medicinal use in the United States. Other Schedule I substances include heroin, LSD, mescaline, and methaqualone.
But recent activity in Washington has legislators in every aisle waving banners for hemp. So far, 20 states have stepped up to encourage industrial hemp production.5 On February 7, 2014, the 2013 Farm Bill6 was signed into law, legitimizing industrial hemp as distinct, and authorizing university and State departments of agriculture (where it’s legal) for research or pilot programs. On January 8, 2015, The Industrial Hemp Farming Act of 2015, S. 134, was introduced in the U.S. Senate. 
Medical cannabis (or medical marijuana) refers to the use of cannabis and its constituent cannabinoids, to treat disease or improve symptoms. Cannabis is used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms.[102][103] Cannabinoids are under preliminary research for their potential to affect stroke.[104]
Some immediate undesired side effects include a decrease in short-term memory, dry mouth, impaired motor skills and reddening of the eyes.[49] Aside from a subjective change in perception and mood, the most common short-term physical and neurological effects include increased heart rate, increased appetite and consumption of food, lowered blood pressure, impairment of short-term and working memory,[50][51] psychomotor coordination, and concentration.
Cannabis can be prepared into various foods generally called ‘edibles’. It takes between 1-3 hours to feel the effects after eating cannabis.2 Impatient or naïve users may believe they have not taken enough to feel the effects, and if they consume more they may find later that the psychoactive effects are unpleasantly strong. When edible products have inconsistent levels of THC even experienced users may find it difficult to regulate the amount consumed.
As of March 2016, more than half of the 50 states have laws that allow for some hemp production, according to this chart. Yet, many states, such as California, where Jungmaven is based, will only allow for industrial hemp cultivation when federal law coincides with state law. That is, when Congress passes a bill permitting industrial hemp across the US. Currently, Jungmann imports his hemp from China, but he’s confident Congress will pass the bill legalizing industrial farming of hemp in July.
In addition to acting on the brain, CBD influences many body processes. That’s due to the endocannabinoid system (ECS), which was discovered in the 1990s, after scientists started investigating why pot produces a high. Although much less well-known than the cardiovascular, reproductive, and respiratory systems, the ECS is critical. “The ECS helps us eat, sleep, relax, forget what we don’t need to remember, and protect our bodies from harm,” Marcu says. There are more ECS receptors in the brain than there are for opioids or serotonin, plus others in the intestines, liver, pancreas, ovaries, bone cells, and elsewhere.
Yet the DEA has stated unequivocally that it considers CBD to be illegal under the Controlled Substances Act. “CBD derived from the cannabis plant is controlled under Schedule I of the CSA because it is a naturally occurring constituent of marijuana,” Joseph Rannazzisi, the deputy assistant administrator of the DEA, told a congressional panel in June. “While there is ongoing research into a potential medical use of CBD, at this time, CBD has no currently accepted medical use in the USA.” Moreover, DEA spokesman Eduardo Chavez told the New Republic that Medical Marijuana, Inc.’s in-house opinion with regards to CBD has no merit. “The bottom line,” Chavez said, “is the oil is part of the marijuana plant, and the marijuana plant is currently a Schedule I controlled substance under federal law.”
Preclinical research suggests that emetic circuitry is tonically controlled by endocannabinoids. The antiemetic action of cannabinoids is believed to be mediated via interaction with the 5-hydroxytryptamine 3 (5-HT3) receptor. CB1 receptors and 5-HT3 receptors are colocalized on gamma-aminobutyric acid (GABA)-ergic neurons, where they have opposite effects on GABA release.[35] There also may be direct inhibition of 5-HT3 gated ion currents through non–CB1 receptor pathways. CB1 receptor antagonists have been shown to elicit emesis in the least shrew that is reversed by cannabinoid agonists.[36] The involvement of CB1 receptor in emesis prevention has been shown by the ability of CB1 antagonists to reverse the effects of THC and other synthetic cannabinoid CB1 agonists in suppressing vomiting caused by cisplatin in the house musk shrew and lithium chloride in the least shrew. In the latter model, CBD was also shown to be efficacious.[37,38]
Cannabis Indica – The annual plant of the Cannabaceae family is considered a species of the genus Cannabis, but separate from Cannabis sativa, and originating in the Hindu Kush Mountains and suited for cultivation in temperate climates. Used to induce sleep, the plant is described as relatively short and conical with dense branches and short, broad leaves, while Cannabis sativa is tall with fewer branches and long, narrow leaves.

Indeed, hemp oil products have grown out of a market largely devoid of regulations or safety protocols. The state of the CBD industry harks back to the age of elixirs and potions hawked from covered wagons to the awed denizens of pioneer towns. There are no industrywide standards in place to ensure that CBD oils are consistently formulated batch-to-batch. There is no regulatory body screening products for pesticides, heavy metals, solvent residues, and other dangerous contaminants. The laboratories that companies contract to test their CBD products are themselves neither standardized nor consistently regulated. No medical research exists to recommend how much CBD a patient should take, nor is there detailed, reliable documentation of how CBD interacts with most epilepsy medications.

There are many ways to prepare cannabis for consumption. And while final marijuana products may come in many forms, each aims to provide rich concentrations of the terpenes, cannabinoids, and other desirable compounds the marijuana plant produces. From the simple process of drying and curing marijuana flowers, to the sophisticated chemistry of producing cannabis concentrates, here’s a guide to the most common forms of cannabis.
Van Roekel (1994) has pointed out that Egyptian papyrus sheets are not “paper,” because the fiber strands are woven, not “wet-laid;” the oldest surviving paper is over 2,000 years of age, from China, and was made from hemp fiber (Fleming and Clarke 1998). Until the early 19th century, hemp, and flax were the chief paper-making materials. In historical times, hemp rag was processed into paper. Using hemp directly for paper was considered too expensive, and in any event the demand for paper was far more limited than today. Wood-based paper came into use when mechanical and chemical pulping was developed in the mid 1800s in Germany and England. Today, at least 95% of paper is made from wood pulp.
Epidiolex is the first FDA-approved treatment in the U.S. that contains a purified drug substance derived from marijuana -- CBD -- and the first treatment for Dravet syndrome. In September 2018 the FDA rescheduled cannabidiol from a C-I controlled substance to a C-V controlled substance, meaning it has a proven medical use but a low risk of abuse. This change allows Epidiolex to be marketed in the U.S.
Australia's National Cannabis Prevention and Information Centre (NCPIC) states that the buds (flowers) of the female cannabis plant contain the highest concentration of THC, followed by the leaves. The stalks and seeds have "much lower THC levels".[152] The UN states that leaves can contain ten times less THC than the buds, and the stalks one hundred times less THC.[149]

A panellized system of hemp-lime panels for use in building construction is currently under test in a European Union-funded research collaboration led by the University of Bath. The panels are being designed to assure high-quality construction, rapid on-site erection, optimal hygrothermal performance from day one, and energy- and resource-efficient buildings. The 36-month-long work programme aims to refine product and manufacturing protocols, produce data for certification and marketing, warranty, insurance cover, and availability of finance. It also includes the development of markets in Britain, France, and Spain.[32]